Attorneys general for 20 states have filed a lawsuit against the Centers for Medicare and Medicaid Services, claiming a recent final rule will make it unnecessarily difficult to get health insurance ...

Bringing clinicians, nurses and other staff impacted by the workflow into each AI initiative's design and implementation process can help ensure adoption, says the University of Maryland Medical ...

Centene has completed its divestiture of Apixio, an artificial intelligence platform that enables value-based care. The company was divested to New Mountain Capital. The insurer entered into a ...

Autonomous AI coding improved Mercyhealth's revenue cycle performance and eased the heavy lifting that went with a greater volume of claims, said Kelly Pierson, director of coding and clinical ...

Humana plans to exit some of its least profitable Medicare Advantage markets in 2027, a move that is expected to impact an estimated 600,000 members. Rather than cut uniformly across the board, Humana ...

UnitedHealth Group is under investigation by the U.S. Department of Justice for alleged criminal healthcare fraud, according to The Wall Street Journal, citing anonymous sources familiar with the ...

The Centers for Medicare & Medicaid Services has announced the end of Part D subsidies for standalone prescription drug plans ...

Chicago-based Huron Consulting Group on Tuesday said it will buy Studer Group for $325 million in a move that will create one of the largest healthcare consulting groups in the field. The combined ...

In a rebrand of its health services portfolio, Cigna is launching Evernorth, which includes pharmacy benefit manager Express Scripts, specialty pharmacy Accredo and eviCore healthcare, which provides ...

Yale New Haven Health, which is among the largest providers of Medicaid services in Connecticut, is advancing efforts to enroll patients who qualify for Medicaid but who are not currently enrolled.

Optum Rx has signaled a shift to a cost-based pharmacy reimbursement model that's intended to have pharmacies pay more for brand-name drugs and less for generics. The model will reduce variation in ...

A third of survey respondents identified measurable cost savings as the most important outcome they expect from AI ...